Assessment of patients with fibromyalgia syndrome

Journal of Musculoskeletal Pain

Volumn 16, Issue 1-2, 2008, Pages 75-83

  Mease, Phillip J ^a  

^a Seattle Rhumatology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PREGABALIN;

ANALYSIS; AWARENESS; CHRONIC PAIN; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; EXERCISE; FATIGUE; FIBROMYALGIA; HUMAN; INFORMATION PROCESSING; METHODOLOGY; MOOD DISORDER; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERFORMANCE; PHYSICIAN; PSYCHIATRY; PSYCHOLOGY; QUALITY OF LIFE; REVIEW; RIGIDITY; SLEEP; SLEEP DISORDER;

EID: 67949085138     PISSN: 10582452     EISSN: 15407012     Source Type: Journal    
DOI: 10.1080/10582450801960347     Document Type: Review

References (46)

1. Mease P: Fibromyalgia Syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 32: 6-21, 2005.
2. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33: 160-172, 1990.
3. Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 18: 728-733, 1991.
4. Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand, CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ: Fibromyalgia syndrome. J Rheumatol 32: 2270-2277, 2005.
5. Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell IJ, Simon LS, Spaeth M, Williams DA, Crofford LJ: Fibromyalgia Syndrome. J Rheumatol 34: 1415-1425, 2007.
6. Turk DC, Dworkin R, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon LS, Stauffer JW, Stein W, Tollett J, Witter J: Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 106: 337-345, 2003.
7. Turk DC, Dworkin R, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW: Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 125: 208-215, 2006.
8. Rowe G, Wright G, Bolger F: Delphi. A reevalu-ation of research and theory. Technological Forecasting and Social Change 39: 235-251, 1991.
9. Delbecq AL, VandeVen AH, Gustafson DH: Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes. Scott-Foresman & Co., Glenview, IL, 1975.
10. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL: Defining the clinically important difference in pain outcome measures. Pain 88: 287-294, 2000.
11. Farrar JT, Young JP, Jr., LaMoreaux L, Werth JL, Poole RM: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94: 149-158, 2001.
12. Gendreau M, Hufford MR, Stone AA: Measuring clinical pain in chronic widespread pain: Selected methodological issues. Best Pract Res Clin Rheumatol 17: 575-592, 2003.
13. Gracely RH, Grant MA, Giesecke T: Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 17: 593-609, 2003.
14. Henriksson CM: Longterm effects of fibromyalgia on everyday life. A study of 56 patients. Scand J Rheumatol 23: 36-41, 1994.
15. Melzack R: The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1: 277-299, 1975.
16. Melzack R: The short-form McGill Pain Questionnaire. Pain 30: 191-197, 1987.
17. Mengshoel AM, Forre O: Pain and fatigue in patients with rheumatic disorders. Clin Rheumatol 12: 515-521, 1993.
18. Littlejohn G: A database for fibromyalgia. Rheum Dis Clin North Am 21: 527-557, 1995.
19. Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, Williams DA, Mease P, McLean SA, Clauw D: Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 32: 1975-1985, 2005.
20. Crofford L, Rowbotham M, Mease P, Russell IJ, Dworkin RH, Corbin AE, Young JP, Jr., LaMoreaux LK, Martin SA, Sharma U: Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis and Rheum 52: 1264-1273, 2005.
21. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50: 2974-2984, 2004.
22. Arnold LM, Rosen A, Pritchett YL, D'Souza D, Goldstein DJ, Iyengar S, Wernicke J: Duloxetine in the treatment of fibromyalgia in women-results from two clinical trials. Pain 119: 5-15, 2005.
23. Martinez-Lavin M, Lopez S, Medina M, Nava A: Use of the Leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. Semin Arthritis Rheum 32: 407-411, 2003.
24. Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA: A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 24: 377-383, 1997.
25. Holman AJ, Myers RR: A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis and Rheum 52: 2495-2505, 2005.
26. Russell IJ, Bennett RM, Michalek JE: Sodium oxybate relieves pain and improves sleep in fibromyalgia syndrome [FMS]: A randomized, double-blind, placebo-controlled, multi-center clinical trial. ACR/ARHP Scientific Meeting Program Book Supplement: Late-breaking abstracts, 2005.
27. Belza BL, Henke CJ, Yelin EH, Epstein WV, Gilliss CL: Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 42: 93-99, 1993.
28. Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39: 315-325, 1995.
29. Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health Qual Life Outcomes 1: 79, 2003.
30. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46: 1121-1123, 1989.
31. Stewart AL, Hays RD, Ware JE: The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26: 724-735, 1988.
32. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM: A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 41: 313-321, 1988.
33. Ware JEJ, Sherbourne CD: The MOS 36-Item Short Form Health Survey (SF-36): Conceptual framework and item selection. Med Care 30: 473-483, 1992.
34. Neumann L, Berzak A, Buskila D: Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: Utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29: 400-408, 2000.
35. Cieza A, Stucki G, Weigl M, Kullman L, Stoll T, Kamen L, Kostanjsek N, Walsh N: ICF Core Sets for chronic widespread pain. J Rehabil Med 44: 63-68, 2004.
36. CiezaA, GeyhS,Chatterji S, KostanjsekN, Ustun B, Stucki G: ICF linking rules: An update based on lessons learned. J Rehabil Med 37: 212-218, 2005.
37. McGahuey CA, Gelenber AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R: The Arizona Sexual Experiences Scale (ASEX): Reliability and validity. J Sex Marital Ther 26: 25-40, 2000.
38. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J:An inventory for measuring depression. Arch Gen Psychiatry 4: 561-751, 1961.
39. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20: 22-57, 1998.
40. Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56: 893-897, 1988.
41. Turk DC, Monarch ES, Williams AD: Psychological evaluation of patients diagnosed with fibromyalgia syndrome: A comprehensive approach. Rheum Dis Clin North Am 28: 219-233, 2002.
42. Retherford RD: Statistical methods for casual analysis. John Wiley & Sons, New York, 1993.
43. Glass JM: Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: New trends and future directions. Curr Rheumatol Rep 8: 425-429, 2006.
44. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A: Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol 16: 93-104, 1994.
45. Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR: Responsiveness offibromyalgia clinical trial outcome measures. J Rheumatol 27: 2683-2691, 2000.
46. Simms RW, Felson DT, Goldenberg DL: Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 18: 1558-1563, 1991.